An early stage biotechnology company that uses AI to identify and design novel molecules to inhibit metabolism for the treatment of orphan oncology/rare tumour indications seeks an Australia research partner.
Subscribe to the Market Information Package (MIP)
A MIP subscription is required to access this content.
The MIP provides opportunities, market insights, and data to support Australia's international education and training sector.
Find out more about the MIP, eligibility and fees